| Literature DB >> 27408829 |
Navid Ziaei-Darounkalaei1, Mehrdad Ameri2, Taghi Zahraei-Salehi3, Omid Ziaei-Darounkalaei4, Tahereh Mohajer-Tabrizi5, Lotfollah Bornaei6.
Abstract
The attempts via introducing many methods have been conducted to select the best antibiotic combination in the treatment of seriously ill patients. Operational or interpretational complexity or time-consuming along with sufficient accuracy led to postpone routine clinical use of these tests until today, despite the urgent need for them. By this study and proposed method, selection of the best double antibiotic synergistic combination against resistant pathogen is simply same as Kirby-Bauer antibiotic susceptibility test. It seems, precise and reliable results (very low coefficient of variation) will be introduced it as a routine accurate diagnostic doubled antimicrobial synergism test.•The objective of this study was to introduce a novel method in antibiotic interaction detection.•It demonstrates high sensitivity and accuracy.•Easy implementation by routine microbiology labs materials and equipment and so easy stand-alone interpretation seems to make it friendly test be able to replacing the previous methods.Entities:
Keywords: AZDAST antibiotic double combination
Year: 2016 PMID: 27408829 PMCID: PMC4929268 DOI: 10.1016/j.mex.2016.01.002
Source DB: PubMed Journal: MethodsX ISSN: 2215-0161
Materials and details used in the present study (new method and disk approximation technique). All the listed materials are similar to the routine clinical disk diffusion antibiogram; only the ATCC bacteria have been used as inocula.
| Parameter | Description | Manufacturer/specifications |
|---|---|---|
| Inoculums | ||
| Bacteria | ATCC 25923 | |
| ATCC 25922 | ||
| Colony suspension method | Direct/by saline suspension | 0.9% NaCl (w/v) |
| Inoculum density | 0.08–0.10 equiv. to the 0.5 McFarland | Spectrophotometer: PG Instrument, T80+, OD625nm |
| Antibiotics | ||
| Antibiotics (paper disks) | Penicillin G (1 Unit) | Padtan-TEB Co., Tehran, Iran |
| Paper disk diameter | 6.4 mm | |
| Paper disk thickness | 1 mm | |
| Antibiotic combinations | Penicillin G and Gentamicin | Synergistic combination |
| Erythromycin and Clindamycin | Antagonistic combination | |
| Culture plates | ||
| Petri plate diameter | 12 cm/glass | TGI™ |
| Petri plate material | Glass | |
| Medium | Mueller-Hinton agar | Merck KGaA, Darmstadt, Germany |
| Medium contributor | 50 mL graduated cylinder | DURAN® Measuring Cylinder |
| Autoclaving medium container | Autoclavable100 mL laboratory glass bottle with cap and pouring ring | TGI™ |
| Volume of medium | 40 mL | |
| Depth of medium | 3.5 mm | Three to 4 mm is acceptable (data has not shown here), but in this study the approximate depth of 3.5 mm has been applied |
Fig. 1Completed AZDAST petri plate before pouring agar: Top-center: combination position, right and left doubled: cummulation positions and down right and left single: deep Kirby-Baure disk susceptibility test.
Fig. 2Compositional separate plates of AZDAST consist of deep Kirby-Baure plate, cummulation plate and combination plate.
Interpretation guideline of the new method.
| The combination result from AZDAST petri plate | AZDAST interpretation on the combination | Equivalent definitions in slang | Examples | |
|---|---|---|---|---|
| Antibiotics | Results (mm) | |||
| If the | Synergistic | 1 + 1 = 3 | Pen | |
| Gen | 30 | |||
| Pen + Pen | 50 | |||
| Gen + Gen | 33 | |||
| If one of the | Potentiation (enhancement) | 0 + 1 = 2 | Pen | 0 |
| Gen | ||||
| Pen + Pen | 0 | |||
| Gen + Gen | 27 | |||
| If the | Antagonistic | 1 + 1 = 0 | Ery | 32 |
| Clin | ||||
| Ery + Ery | 34 | |||
| Clin + Clin | 43 | |||
| If the | Additive | 1 + 1 = 2 | Gen | 25 |
| Tet | 25 | |||
| Gen + Gen | 28 | |||
| If the | Not distinguishable | 1 + 0 = 1 | Amp | 10 |
| Amp + Amp | 15 | |||
| Tet + Tet | 27 | |||
If consider two drugs, as a and b with the zones of growth inhibition as A and B respectively along with the AB for the combination position and AA and BB for cummulation positions of a and b in the AZDAST petri plate. Pen, Penicillin; Gen, Gentamycin; Ery, Erythromycin; Clin, Clindamycin; Tet, Tetracycline; Amp, Ampicillin.
Fig. 3An impressive synergism has been shown against a multiresistant wild E. coli isolate by AZDAST. [This photo is the first try to implementing the idea of AZDAST.] Photo by authors.
Fig. 4Pattern used for evaluating diffusion properties of antibiotics in the new method.
Results of new method on penicillin G and gentamicin on Staphylococcus aureus and Escherichia coli.
| Bacteria | Analysis | Disk combinations in the AZDAST petri plate (mm) | ||||
|---|---|---|---|---|---|---|
| Pen | Gen | Pen + Gen | Pen + Pen | Gen + Gen | ||
| Means of zones of inhibition | 30.38 | 50.00 | 33.00 | |||
| Standard deviation | 1.83 | 2.07 | 2.05 | 2.67 | 2.27 | |
| Coefficient variation | 0.04 | 0.07 | 0.04 | 0.05 | 0.07 | |
| Means of zones of inhibition | 0.00 | 0.00 | 27.75 | |||
| Standard deviation | 0.00 | 0.64 | 0.74 | 0.00 | 0.71 | |
| Coefficient variation | 0.00 | 0.02 | 0.03 | 0.00 | 0.03 | |
Pen is a symbol of first antibiotic disk (Penicillin G, 1 Unit) and Gen for second one (Gentamicin, 10 μg). Petri dish 12 cm, medium volume: 40 mL, medium depth: 3.5 mm.
Results of new method on erythromycin and clindamycin on Staphylococcus aureus and Escherichia coli.
| Bacteria | Analysis | Disk combinations in the AZDAST petri plate (mm) | ||||
|---|---|---|---|---|---|---|
| Ery | Clin | Ery + Clin | Ery + Ery | Clin + Clin | ||
| Means of zones of inhibition | 32.13 | 34.50 | 43.88 | |||
| Standard deviation | 0.83 | 1.41 | 1.93 | 1.93 | 1.81 | |
| Coefficient variation | 0.03 | 0.03 | 0.05 | 0.06 | 0.04 | |
| Means of zones of inhibition | 0.00 | 12.25 | 0.00 | |||
| Standard deviation | 1.07 | 0.00 | 3.36 | 1.28 | 0.00 | |
| Coefficient variation | 0.11 | 0.00 | 0.41 | 0.10 | 0.00 | |
Ery is a symbol of first antibiotic disk (Erythromycin, 5 μg) and Clin for second one (Clindamycin, 2 μg). Petri dish: 12 cm, medium volume: 40 mL, medium depth: 3.5 mm.
Comparison table of two methods on detecting synergistic combination of penicillin G and gentamicin.
| Bacteria | Cases/incidence rate | AZDAST | Disk approximation | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Syn | Ant | Add | ND | Syn | Ant | Add | ND | ||
| Total (No) | 6 | 2 | 0 | 0 | 0 | 0 | 8 | – | |
| Incidence (%) | 75 | 25 | 0 | 0 | 0 | 0 | 100 | – | |
| Overall interpretation | On incidence | Syn | Add | ||||||
| On mean | Syn | – | |||||||
| Total (No) | 3 | 0 | 0 | 5 | 4 | 0 | 4 | – | |
| Incidence (%) | 38 | 0 | 0 | 63 | 50 | 0 | 50 | – | |
| Overall interpretation | On incidence | Syn | Syn and/or ND | ||||||
| On mean | Syn | – | |||||||
Syn: synergistic, Ant: antagonistic, Add: additive, ND: not distinguishable.
8 plates in each group have been inoculated.
DATA were dedicated from Table 3.
Comparison table of two methods on detecting antagonistic combination of erythromycin and clindamycin.
| Bacteria | Cases/incidence rate | AZDAST | Disk approximation | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Syn | Ant | Add | ND | Syn | Ant | Add | ND | ||
| Total (No) | 3 | 5 | 0 | 0 | 1 | 0 | 7 | – | |
| Incidence (%) | 37.5 | 62.5 | 0 | 0 | 13 | 0 | 88 | – | |
| Overall interpretation | On incidence | Ant | Add | ||||||
| On mean | Ant | ||||||||
| Total (No) | 2 | 4 | 0 | 2 | 0 | 0 | 8 | – | |
| Incidence (%) | 25 | 50 | 0 | 25 | 0 | 0 | 100 | – | |
| Overall interpretation | On incidence | Ant | Add | ||||||
| On mean | Ant | ||||||||
Syn: synergistic, Ant: antagonistic, Add: additive, ND: not distinguishable.
8 plates in each group have been inoculated.
DATA were dedicated from Table 4.
| Spectrophotometer | (OD625) or 0.5 McFarland turbidity standard |
| Autoclave | |
| Magnetic Heater Stirrer | Adjusted on 44–48 °C approximately |
| Water bath | (44–48 °C) |
| Incubator | (Gravity convection microbiology incubator) |
| Graduated cylinder | (50 mL) |
| Autoclavable glass bottle | (100 mL with cap and pouring ring) |
| Glass petri plate | (12 cm) |
| Antibiotics paper disks | (Padtan-TEB Co., Tehran, Iran) |
| Mueller-Hinton agar | (Merck KGaA, Darmstadt, Germany) |
| Samples | Patients pathogens (Clinical referrals) |